ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 120 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $558 | -99.9% | 170 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $782,000 | -59.7% | 54,477 | -59.1% | 0.00% | -60.0% |
| Q2 2020 | $1,942,000 | -92.1% | 133,254 | -95.4% | 0.01% | -93.1% |
| Q1 2020 | $24,590,000 | -34.6% | 2,889,541 | +26.5% | 0.07% | -14.3% |
| Q4 2019 | $37,625,000 | +19.7% | 2,284,473 | +2.6% | 0.08% | +9.1% |
| Q3 2019 | $31,426,000 | +51.9% | 2,225,666 | +116.4% | 0.08% | +54.0% |
| Q2 2019 | $20,683,000 | -42.4% | 1,028,507 | +13.9% | 0.05% | -43.8% |
| Q1 2019 | $35,906,000 | +68.9% | 903,307 | +47.6% | 0.09% | +53.4% |
| Q4 2018 | $21,264,000 | +8.2% | 612,100 | +28.8% | 0.06% | +26.1% |
| Q3 2018 | $19,658,000 | +12.5% | 475,400 | 0.0% | 0.05% | -9.8% |
| Q2 2018 | $17,471,000 | -6.0% | 475,400 | -0.2% | 0.05% | -5.6% |
| Q1 2018 | $18,585,000 | – | 476,541 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |